Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures (Natalie Breymeyer/Axios)
Mithrl, an AI infrastructure company for biopharma, raised a $20 million Series A, CEO Vivek Adarsh tells Axios exclusively.
We haven't written up this one. Techmeme has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
